InvestorsHub Logo
Followers 0
Posts 84
Boards Moderated 0
Alias Born 12/17/2018

Re: None

Thursday, 03/07/2019 6:19:58 AM

Thursday, March 07, 2019 6:19:58 AM

Post# of 108191
Possibly us , but we know immune design IMNZ is the mentioned target for Merck’s dollars.
Well with every takeover there is room for us in another biotech fund or ETF.
For the record , I have always been long ADXS and have not and will not sell Adxs.
I continue to accumulate shares . Again, I am hoping for ADXS to have positive clinical results.
I don’t know Terry . I don’t know anyone on this board. I was born in Philadelphia and have been associated with many oncologic institutions , one being the Hospital of the University of Pennsylvsnia which is a top notch medical center .
Hoping ADXS clinical studies are defeating chemotherapy .
I appreciate reading the information snd efforts of everyone on this board . Sometimes it gets desperately negative and that’s my buying opportunity . Thank you !
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News